GL1X · GenesisL1 explorer

Research workbench

The crystal structure of uPA in complex with HMA-55F

Analyse The crystal structure of uPA in complex with HMA-55F in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AG7
Type
protein
Length
245 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.9
Source
Homo sapiens
Molecule
Urokinase-type plasminogen activator
EC
3.4.21.73
UniProt
P00749
Ligands
H55
Pockets
1 · best druggability 0.43

Structure

x-ray diffraction · resolution 1.9 · 1 distinct chain · 11% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
UUrokinase-type plasminogen activator (EC 3.4.21.73)protein24511% helix, 39% strandP00749

Ligands and binding sites

  • H55 · 3,5-diamino-N-carbamimidoyl-6-(1-methyl-1H-pyrazol-4-yl)pyrazine-2-carboxamide · ligand · chains U

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11630.430.7432H55

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 6AG7 · The crystal structure of upa in complex with hma-55F · the same entry in another collection · chain U against U, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.